From Casetext: Smarter Legal Research

Underwriters at Lloyd's Subscribing to Cover Note B1526MACAR1800089 v. Abaxis, Inc.

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
Jun 15, 2020
Case No. 19-cv-02945-PJH (N.D. Cal. Jun. 15, 2020)

Opinion

Case No. 19-cv-02945-PJH

06-15-2020

UNDERWRITERS AT LLOYD'S SUBSCRIBING TO COVER NOTE B1526MACAR1800089, Plaintiff, v. ABAXIS, INC., et al., Defendants.


ORDER GRANTING MOTION FOR LEAVE TO AMEND; DENYING WITHOUT PREJUDICE MOTION TO DISMISS; AND DENYING MOTION FOR LEAVE TO RESPOND

Re: Dkt. Nos. 67, 68, 75

Before the court is defendants Abaxis, Inc. ("Abaxis") and Zoetis, Inc.'s ("Zoetis" and together with Abaxis, "defendants") motion for leave to file a second amended answer and crossclaim. Also before the court are cross-defendant C.H. Robinson Worldwide, Inc.'s ("CHR" or "cross-defendant") motion to dismiss and plaintiff Underwriters at Lloyd's Subscribing to Cover Note B1526MACAR1800089's ("Underwriters" or "plaintiff") motion for leave to respond. The matters are fully briefed and suitable for decision without oral argument. Having read the parties' papers and carefully considered their arguments and the relevant legal authority, and good cause appearing, the court hereby rules as follows.

BACKGROUND

The complaint in this action was filed by plaintiff on May 29, 2019. Dkt. 1. This court's April 6, 2020 order contains a more thorough recitation of the underlying factual background of this case. See Dkt. 63. To briefly summarize, this case involves the delivery of certain pharmaceutical products from the manufacturer of those products (defendants) to Henry Schein Animal Health and Butler Animal Health Supply, LLC ("Schein"), products that were ruined en route to Schein. See id. at 2. Plaintiff is a group of insurers that paid out Schein's insurance claim and now asserts that party's claims. TCSL, Inc. ("TCSL") was the carrier of the shipment in question and CHR was alleged to have issued the bill of lading and coordinated communication between TCSL and Schein. Id.

TCSL has not appeared in this action.

The relevant procedural history is as follows. On June 26, 2019, plaintiff filed a first amended complaint (Dkt. 16), to which defendants Abaxis and Zoetis filed a motion to dismiss (Dkt. 20). Upon the parties' stipulation, plaintiff filed the operative Second Amended Complaint ("SAC") and defendants agreed to refile their motion to dismiss. The SAC dismissed two of three claims alleged against Abaxis and Zoetis, leaving only a breach of contract claim pled against them. Dkt. 28. On September 23, 2019, plaintiff voluntarily dismissed all claims against TCSL. (Dkt. 35), and on October 17, 2019, plaintiff voluntarily dismissed all claims against CHR pursuant to a settlement agreement, (Dkt. 38).

On November 20, 2019, this court denied defendants Abaxis and Zoetis's motion to dismiss (Dkt. 40), and then on December 4, 2019, defendants filed an answer to the SAC and crossclaims ("Crossclaim") against TCSL and CHR (Dkt. 42). The Crossclaim against CHR incorporated by reference the allegations in the SAC and further alleged that TCSL, acting at the direction of or in conjunction with CHR, negligently mishandled the shipment of pharmaceuticals obtained from Abaxis. Crossclaim ¶ 20. In response to defendants' Crossclaim, CHR filed a Rule 12(b)(6) motion to dismiss. Dkt. 42. On April 6, 2020, this court granted CHR's motion and granted leave to amend the crossclaim within twenty-one days. Dkt. 63.

On April 27, 2020, defendants Abaxis and Zoetis filed their First Amended Answer and Crossclaim ("FACC," Dkt. 66) as well as the present motion requesting leave to file a proposed Second Amended Answer & Crossclaim ("SACC," Dkt. 67-2) against cross-defendants, CHR and TCSL. Mtn. at 1. Defendants seek leave to file new crossclaims for negligence, negligent misrepresentation, conversion, and negligent interference with economic advantage, as well as their previously asserted crossclaims for equitable indemnification, and contribution. Id. at 4.

While the parties were briefing the motion for leave to amend, CHR filed a motion to dismiss the FACC on May 11, 2020. Dkt. 68. On May 26, 2020, defendants filed an opposition to CHR's motion to dismiss. Dkt. 74. While not directly involved in the crossclaim or the motion to dismiss, the opposition contained statements that caused plaintiff to file a motion seeking to address purportedly frivolous allegations in defendants' opposition brief. Dkt. 75.

DISCUSSION

A. Legal Standard

Federal Rule of Civil Procedure 15 requires that a plaintiff obtain either consent of the defendant or leave of court to amend its complaint once the defendant has answered, but "leave shall be freely given when justice so requires." Fed. R. Civ. P. 15(a); see, e.g., Chodos v. W. Publ'g Co., 292 F.3d 992, 1003 (9th Cir. 2002) (leave to amend granted with "extreme liberality"). Leave to amend is thus ordinarily granted unless the amendment is futile, would cause undue prejudice to the defendants, or is sought by plaintiffs in bad faith or with a dilatory motive. Foman v. Davis, 371 U.S. 178, 182 (1962); Smith v. Pac. Properties & Dev. Corp., 358 F.3d 1097, 1101 (9th Cir. 2004). While courts should consider all such factors, "the crucial factor is the resulting prejudice to the opposing party." Howey v. United States, 481 F.2d 1187, 1190 (9th Cir. 1973).

B. Analysis

1. Summary of Defendants' Proposed Second Amended Answer & Crossclaim

While the FACC only brings two claims against TCSL and CHR for indemnification and contribution, the proposed SACC would allege six crossclaims against each of TCSL and CHR: (1) negligence; (2) negligent misrepresentation; (3) conversion; (4) negligent interference with economic advantage; (5) equitable indemnification; and (6) contribution. Dkt. 67-2. Because only CHR opposes the motion to amend, the court briefly describes the proposed crossclaims asserted against CHR.

Defendants' first crossclaim for negligence alleges that CHR breached its duty of care when TCSL, acting at the direction of CHR, took goods from defendants it did not have a right to receive or transport. Id. ¶¶ 29-41. Defendants' second crossclaim for conversion alleges that TCSL acted on behalf of CHR when it mishandled the shipment at issue, which caused permanent damage to its contents. Id. ¶¶ 42-48. Defendants' third crossclaim for negligent misrepresentation alleges that a TCSL employee, who was dispatched at the direction of CHR, orally represented that he was authorized to receive and transport the pharmaceutical products at issue, even though the employee knew he did not have the power to do so. Id. ¶¶ 49-59. Defendants' fourth crossclaim for negligent interference with prospective economic advantage alleges that the negligent conduct carried out at the direction of CHR prevented defendants from realizing the economic benefits of their contractual relationship with Schein. Id. ¶¶ 60-70.

Defendants' proposed SACC brings claims against both TCSL and CHR; however, defendants separated the claims into, essentially, two separate complaints with the same paragraph numbers. Because only CHR is opposing the motion to amend, the court refers only to the paragraph numbers pertaining to CHR, starting on page 24 of the proposed SACC. --------

Defendants also re-allege their crossclaims for equitable indemnification and contribution. Id. ¶¶ 71-80.

2. Whether Defendants' Amendment Meets the Requirements of Rule 15

Under Rule 15, "[t]he court should freely give leave [to amend the complaint] when justice so requires." Fed. R. Civ. P. 15(a)(2). This policy is "to be applied with extreme liberality." Eminence Capital, LLC v. Aspeon, Inc., 316 F.3d 1048, 1051-52 (9th Cir. 2003). In determining whether to grant leave to amend, the court applies the factors articulated in Foman v. Davis:

In the absence of any apparent or declared reason—such as undue delay, bad faith or dilatory motive on the part of the movant, repeated failure to cure deficiencies by amendments previously allowed, undue prejudice to the opposing party by virtue of allowance of the amendment, futility of amendment, etc.—the leave sought should, as the rules require, be "freely given."
371 U.S. at 182.

Prejudice is the "touchstone of the inquiry under Rule 15(a)" and the "party opposing amendment 'bears the burden of showing prejudice.'" Eminence Capital, 316 F.3d at 1052 (quoting Lone Star Ladies Inv. Club v. Schlotzsky's Inc., 238 F.3d 363, 368 (5th Cir. 2001); and DCD Programs, Ltd. v. Leighton, 833 F.2d 183, 185 (9th Cir. 1987)). "Absent prejudice, or a strong showing of any of the remaining Foman factors, there exists a presumption under Rule 15(a) in favor of granting leave to amend." Id. (citing Lowrey v. Tex. A & M Univ. Sys., 117 F.3d 242, 245 (5th Cir. 1997)).

a. Undue Prejudice

Undue prejudice exists "where the 'parties have engaged in voluminous and protracted discovery' prior to amendment, or where '[e]xpense, delay, and wear and tear on individuals and companies' is shown." Utterkar v. Ebix, Inc., No. 14-CV-02250-LHK, 2015 WL 5027986, at *6 (N.D. Cal. Aug. 25, 2015) (alteration in original) (quoting Kaplan v. Rose, 49 F.3d 1363, 1370 (9th Cir. 1994), overruled on other grounds by City of Dearborn Heights Act 345 Police & Fire Ret. Sys. v. Align Tech., Inc., 856 F.3d 605, 609 (9th Cir. 2017); and citing Jackson v. Bank of Haw., 902 F.2d 1385, 1387-88 (9th Cir. 1990)).

Defendants contend that there is no undue prejudice to CHR because CHR has ample time to respond to the proposed claims, through investigation and formal discovery. Mtn. at 11. In response, CHR argues that allowing defendants another attempt to address the deficiencies of their causes of action for indemnity and contribution would result in clear prejudice to CHR. Opp. at 12. CHR also contends that the newly proposed independent tort causes of action will cause prejudice in the expense resulting from bringing a motion to dismiss. Id.

Here, the prejudice to CHR is not undue, as this case is still in the pleading stage and discovery has not yet commenced. Cf. Zivkovic v. S. Cal. Edison Co., 302 F.3d 1080, 1087 (9th Cir. 2002) (holding no abuse its discretion where district court denied leave to amend because motion to amend was filed "only several days before the discovery cut-off and less than three months before the trial was to commence"). Further, the present motion is defendants' first request to amend their complaint to allege independent tort claims and the expense to CHR to file a motion to dismiss is not disproportionate. Thus, the undue prejudice factor weighs in favor of granting the motion and, absent a strong showing of the remaining Foman factors, there is a presumption in favor of granting leave to amend. See Eminence Capital, 316 F.3d at 1052.

b. Futility

Defendants argue that their proposed claims are not be futile because the claims are based on factual allegations that have not been tested by a motion to dismiss. Mtn. at 9-10. In response, CHR advances several arguments as to why granting leave to amend would be futile, including renewing their arguments pertaining to indemnification and contribution as well as substantive arguments attacking the viability of the new claims. See Opp. at 6-12.

Generally, CHR's futility argument seeks to challenge whether the SACC states a claim. Whatever the ultimate conclusion on the viability of defendants' claims, CHR's arguments are better tested at the motion to dismiss stage, rather than through a motion to amend. See Bd. of Trustees of the Auto. Indus. Welfare Fund v. Groth Oldsmobile/Chevrolet, Inc., No. C 09-0465 PJH, 2010 WL 760452, at *3 (N.D. Cal. Mar. 4, 2010) ("This court normally will not rule on the futility of an amendment at the motion to amend stage of the litigation unless the proposed amendment is clearly and unambiguously futile."). The court previously dismissed defendants' indemnification and contribution claims without prejudice and defendants' newly proposed tort claims have not been tested by a motion to dismiss. Given the procedural posture, it is premature to find that the proposed amendment is clearly and unambiguously futile. This factor weighs in favor of granting leave to amend.

The court acknowledges that CHR's pending motion to dismiss will be mooted by the filing of the proposed SACC and that CHR has reserved the right to file a renewed motion to dismiss. Mtn. at 12. The court will permit CHR the opportunity to file a renewed motion to dismiss, which will also mitigate any prejudice to CHR.

c. Bad Faith or Dilatory Motive

Generally, an "amendment should be permitted unless it will not save the complaint or the plaintiff merely is seeking to prolong the litigation by adding new, but baseless legal theories." Griggs v. Pace Am. Grp., Inc., 170 F.3d 877, 881 (9th Cir. 1999) (citing Steckman v. Hart Brewing, Inc., 143 F.3d 1293, 1296 (9th Cir. 1998)).

In their motion, defendants argue there is no bad faith because they have been diligent in their attempts to plead these crossclaims, first as equitable indemnity and contribution and now as independent claims once the court issued its April 6th order dismissing the original equitable indemnity and contribution claims. Mtn. at 8. In response, CHR argues that the only way defendants can successfully hold CHR responsible is through an indemnity and contribution claim, both of which were dismissed in a prior order. Opp. at 5. CHR contends, therefore, that defendants' motive is dilatory because the independent tort claims cannot be asserted to hold CHR liable. Id.

CHR's argument as to dilatory motive depends on the outcome of a future Rule 12(b)(6) claim that tests the viability of defendants' proposed crossclaims. Without presupposing the outcome of such a motion to dismiss, it is not clear that defendants' motive is dilatory. While the court previously dismissed defendants' equitable indemnity and contribution claims, it acknowledged that defendants might be able to allege new factual matter to overcome the deficiencies identified in the order. Thus, it is not clear that defendants seek to prolong the litigation by adding new, baseless legal theories. Accordingly, CHR has not demonstrated bad faith or dilatory motive shown on the part of defendants. / / /

d. Undue Delay

Delay, by itself, is insufficient to justify denial of leave to amend. DCD Programs, Ltd., 833 F.2d at 183-86; see also Hurn v. Ret. Fund Tr. of Plumbing, Heating & Piping Indus. of S. Cal., 648 F.2d 1252, 1254 (9th Cir. 1981). Instead, "[c]ourts previously have found that a party unduly delayed when the party sought to amend a pleading with previously-known facts, particularly when the delay is accompanied by the requisite showing of other Foman factors such as prejudice." Uttekar, 2015 WL 5027986, at *7.

Defendants argue that they sought to amend their crossclaim soon after the court's April 6th order that dismissed without prejudice their crossclaims for indemnity and contribution, and thus, they did not cause undue delay. Mtn. at 9. In response, CHR argues that defendants should have filed these claims when they first answered the SAC in December 2019. Opp. at 6. CHR further contends that the proposed SACC is a last ditch attempt to accomplish what the failed causes of action for indemnity and contribution could not accomplish from the original answer and crossclaim. Id.

Both defendants and cross-defendant raise valid points as to delay. On the one hand, defendants are seeking leave to amend within a few weeks of their original Crossclaim being dismissed without prejudice and within the timeframe for which the court permitted amendment. See Dkt. 63 at 9. On the other hand, cross-defendant raises a point that defendants were aware of the underlying facts in this case and neglected to allege independent tort claims until now. However, this delay is not undue because this case is still in the pleading stage and the parties have not completed discovery. Moreover, the other Foman factors weigh in favor of granting leave to amend. Thus, CHR has not established undue delay in this case and granting leave to amend is warranted.

3. Disposition of Remaining Motions

On May 11, 2020, CHR filed a motion to dismiss the first amended crossclaim. Dkt. 68. Because the court grants defendants' leave to amend, CHR's pending motion will be moot. As indicated herein, CHR will be permitted to file a renewed motion once defendants file their proposed SACC.

Next, defendants filed an opposition to CHR's motion on May 26, 2020. Dkt. 74. In response to certain statements in the opposition, plaintiff filed a motion for leave to respond to frivolous allegations. Dkt. 75. In the opposition brief, defendants state that plaintiff "simply dropped the cause of action for negligence against Abaxis and Zoetis on the understanding that doing so would preclude Abaxis and Zoetis from recovering in equitable indemnity . . . ." Dkt. 74 at 13. Defendants also contend that plaintiff and CHR failed to a good faith determination from the court regarding the settlement between those two parties. Id. at 12-13. Defendants also alleges that plaintiff and CHR's conduct "raises genuine concerns of collusion." Id. at 14.

In response, plaintiff contends that defendants sought the negligence claims against them to be dismissed, through the filing of a prior motion to dismiss and associated communications. Dkt. 75 at 4. With regard to the good faith settlement determination, plaintiff contends that its only claim against CHR sounded in federal law and the good faith settlement determination, which is required under California law, is inapplicable. Id. at 6. Plaintiff also contends that defendants' references to collusion are unprofessional and unsubstantiated. Id. at 8.

The court understands plaintiff's motion as only a request to submit the memorandum of points and authorities in response to defendants' opposition to CHR's motion to dismiss because it is not directly involved in CHR's motion to dismiss. Dkt. 75 at 2. Because the underlying motion to dismiss is being denied without prejudice, defendants' opposition is, therefore, moot. For that reason, plaintiff's motion is essentially mooted and will be denied on that ground alone. The court is cognizant, however, of the issues raised in plaintiff's motion, especially concerning defendants' accusation of collusion between plaintiff and CHR. Accordingly, all parties are warned that all future filings must adhere to Rule 11's requirement for attorneys to certify that they have read any pleadings or motions they file with the court and that such pleadings and motions are well-grounded in fact, have a colorable basis in law, and are not filed for an improper purpose. Fed. R. Civ. P. 11(b).

CONCLUSION

For the foregoing reasons, defendants' motion to amend is GRANTED. Additionally, cross-defendant's motion to dismiss is DENIED WITHOUT PREJUDICE and plaintiff's motion for leave to respond is DENIED. Defendants shall file their proposed second amended answer and crossclaim within 7 days of the filing of this order. Cross-defendant may file a renewed motion or responsive pleading within 21 days of the filing of the second amended answer and crossclaim.

IT IS SO ORDERED. Dated: June 15, 2020

/s/ Phyllis J. Hamilton

PHYLLIS J. HAMILTON

United States District Judge


Summaries of

Underwriters at Lloyd's Subscribing to Cover Note B1526MACAR1800089 v. Abaxis, Inc.

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
Jun 15, 2020
Case No. 19-cv-02945-PJH (N.D. Cal. Jun. 15, 2020)
Case details for

Underwriters at Lloyd's Subscribing to Cover Note B1526MACAR1800089 v. Abaxis, Inc.

Case Details

Full title:UNDERWRITERS AT LLOYD'S SUBSCRIBING TO COVER NOTE B1526MACAR1800089…

Court:UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA

Date published: Jun 15, 2020

Citations

Case No. 19-cv-02945-PJH (N.D. Cal. Jun. 15, 2020)